InVivo Therapeutics Holdings Probability of Future Stock Price Finishing Under 1.38
| NVIVDelisted Stock | USD 1.38 0.07 5.34% |
InVivo |
InVivo Therapeutics Target Price Odds to finish below 1.38
The tendency of InVivo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move below current price in 90 days |
| 1.38 | 90 days | 1.38 | about 88.37 |
Based on a normal probability distribution, the odds of InVivo Therapeutics to move below current price in 90 days from now is about 88.37 (This InVivo Therapeutics Holdings probability density function shows the probability of InVivo Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the stock has the beta coefficient of 1.04 . This indicates InVivo Therapeutics Holdings market returns are correlated to returns on the market. As the market goes up or down, InVivo Therapeutics is expected to follow. Additionally InVivo Therapeutics Holdings has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. InVivo Therapeutics Price Density |
| Price |
Predictive Modules for InVivo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as InVivo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.InVivo Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. InVivo Therapeutics is not an exception. The market had few large corrections towards the InVivo Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold InVivo Therapeutics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of InVivo Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.07 | |
β | Beta against Dow Jones | 1.04 | |
σ | Overall volatility | 0.06 | |
Ir | Information ratio | -0.01 |
InVivo Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of InVivo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for InVivo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| InVivo Therapeutics is not yet fully synchronised with the market data | |
| InVivo Therapeutics may become a speculative penny stock | |
| InVivo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.33 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InVivo Therapeutics Holdings currently holds about 13.03 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
InVivo Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of InVivo Stock often depends not only on the future outlook of the current and potential InVivo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. InVivo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.5 M | |
| Cash And Short Term Investments | 16.4 M |
InVivo Therapeutics Technical Analysis
InVivo Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. InVivo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of InVivo Therapeutics Holdings. In general, you should focus on analyzing InVivo Stock price patterns and their correlations with different microeconomic environments and drivers.
InVivo Therapeutics Predictive Forecast Models
InVivo Therapeutics' time-series forecasting models is one of many InVivo Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary InVivo Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about InVivo Therapeutics
Checking the ongoing alerts about InVivo Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for InVivo Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| InVivo Therapeutics is not yet fully synchronised with the market data | |
| InVivo Therapeutics may become a speculative penny stock | |
| InVivo Therapeutics has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (9.33 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| InVivo Therapeutics Holdings currently holds about 13.03 M in cash with (10.13 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.36, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Other Consideration for investing in InVivo Stock
If you are still planning to invest in InVivo Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the InVivo Therapeutics' history and understand the potential risks before investing.
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |